Health Care • Medical/Dental Instruments
$162.38 ▼ -1.40
(-0.85%)
MKT CAP: $4.10B • VOL: 310.0K
52W L $113 52W H $193
ROARABLE / RQD
D+ • 56/100
PIOTROSKI
8 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$136
MEDIAN
$182
MEAN
$185
HIGH
$221
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ICUI TAPE
ICUI // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $196.48 | $186.74 | 2025-02-14 | $147.77 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $204.60 | $191.61 | 2025-02-06 | $152.64 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $185.11 | $178.62 | 2025-01-29 | $155.88 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $165.63 | — | 2025-01-17 | $159.13 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $142.89 | $154.26 | 2025-01-09 | $144.52 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $193.23 | $168.88 | 2024-12-18 | $141.27 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $157.51 | $164.00 | 2024-12-04 | $151.01 | -4.3% | 48% | C |